I think this drug is worth a lot. The company has given guidance on what it may bring in. Do a little more research. The indication for premature baby's is a small market. The larger market will be for children and adults! So I still think this is a buyout target. I am ahead either way. I sold 2/3 of my position before approval date. The shares I hold are free!!